Hydrophobic modified yarn ball for dental hemostasis as well as preparation method and application of hydrophobic modified yarn ball
By hydrophilizing and hydrophobizing the gauze, spraying hydrophobic silica microspheres to form modified gauze-wrapped cotton balls, the problem of deformation and bleeding delay of traditional dental hemostatic materials is solved, and efficient blood coagulation and hemostatic effect is achieved .
Patent Information
- Application Number
- CN202411161026.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-22
- Publication Date
- 2024-11-26
AI Technical Summary
Traditional dental hemostatic materials such as cotton balls deform and collapse after infiltration of saliva and blood, which cannot provide sufficient compression effect, resulting in delayed blood clot formation and postoperative bleeding, and lack of physiological hemostatic effects.
Hydrophobically modified yarn balls are used to spray hydrophilize and hydrophobize the gauze, and hydrophobize the gauze, to form gauze with an ideal wetting gradient, which is used to wrap degreased cotton balls to improve hemostatic performance.
Resistance to saliva and aggregation of blood components is achieved, which significantly shortens the blood clotting time, improves the efficiency and effect of dental hemostasis, and is better than commercially available products.
Smart Images

Figure CN119015472A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biomedical materials, and specifically to a hydrophobic modified yarn ball for dental hemostasis, a preparation method and use thereof. Background Art
[0002] After tooth extraction, dental implant and periodontal flap surgery, the mucosal wound will produce a series of biological changes to achieve soft tissue healing. The process includes: wound bleeding and blood clot formation within 15-30 minutes, granulation tissue begins to form within a few hours, and connective tissue and epithelial tissue begin to grow within 3 to 4 days. The formation and in situ maintenance of early blood clots are important prerequisites for good healing. Once the blood clot is abnormally formed or falls off prematurely, it will cause severe pain and delayed healing. In clinical practice, cotton balls are routinely used for oral hemostasis. Its main component is natural cellulose, which can quickly absorb blood on the basis of local pressure to achieve the purpose of hemostasis.
[0003] After dental surgery, cotton balls are often applied locally, and patients are advised to bite and compress by themselves. However, in actual application, this method has the following problems: after being infiltrated with a large amount of saliva and blood, ordinary cotton fibers are very easy to deform and collapse, and their volume shrinks. For the majority of middle-aged and elderly patients with weak bite force or missing teeth, this method of hemostasis often fails to achieve sufficient compression effect. Even for patients with normal occlusion, it takes 15-30 minutes for a blood clot to form initially after conventional compression, and there is still local blood oozing 24 hours after the operation, which affects the patient's eating and life after the operation.
[0004] In addition, from the perspective of physiological mechanism, effective hemostasis requires the release of endothelial injury signals, the activation of coagulation factors and blood coagulation. This process requires the participation of formed components in the wound blood. Traditional cotton cellulose not only lacks physiological hemostasis, but also cannot maintain coagulation components on the wound surface. Therefore, it is necessary to improve the existing hemostatic gauze balls to accelerate the formation of blood clots.
[0005] Currently, researchers are working on introducing new materials into oral local hemostasis. For example, Celox, a British company, has launched a chitosan dressing that can be used for oral postoperative hemostasis, which can quickly stop bleeding. However, the product is expensive, which limits its clinical promotion and use. Summary of the invention
[0006] In order to solve the defects of the prior art, the object of the present invention is to provide a hydrophobic modified yarn ball for dental hemostasis and a preparation method thereof.
[0007] The present invention provides a modified gauze, which is obtained by spraying a hydrophobic compound on the gauze, wherein the density of the spraying is 0.1 to 1.5 mg / cm 2 .
[0008] Furthermore, the gauze is a woven gauze or non-woven gauze with a mesh structure;
[0009] The spraying process is electric spray gun spraying, dipping, spin coating, electrostatic spray spraying or chemical vapor deposition spraying;
[0010] The hydrophobic compound is hydrophobic silica microspheres, long-chain alkyl silane, long-chain fatty acid, beeswax or paraffin;
[0011] The density of the spraying is 0.25-1 mg / cm 2 .
[0012] Furthermore, the spraying process is spraying with an electric spray gun;
[0013] The hydrophobic compound is hydrophobic silica microspheres;
[0014] The density of the spraying is 0.5 mg / cm 2 .
[0015] Furthermore, the gauze is hydrophilized gauze.
[0016] Furthermore, the hydrophilization treatment is hydrophilic compound modification, ultraviolet light modification, plasma modification, carboxymethylation modification or cellulase modification.
[0017] Furthermore, the hydrophilic compound modification is a catechol compound modification.
[0018] Furthermore, the hydrophilic compound is modified into dopamine.
[0019] The invention also provides a hemostatic gauze ball, which is composed of the modified gauze and an absorbent cotton ball.
[0020] The present invention also provides a method for preparing the hemostatic gauze ball, which comprises the following steps: assembling the modified gauze and the absorbent cotton ball to obtain the hemostatic gauze ball.
[0021] The present invention also provides use of the modified gauze or hemostatic gauze ball in preparing dental hemostatic materials.
[0022] In summary, the present invention provides a hydrophobic modified gauze ball for dental hemostasis and a preparation method thereof. The hydrophobic modified gauze ball of the present invention is composed of an outer gauze layer and an inner cotton ball, wherein the outer gauze layer is prepared by coating the hydrophobic surface and modifying the hydrophobic silica microspheres. The hydrophobic modified gauze ball of the present invention is used for hemostasis after dental surgery, can resist saliva wetting, and promote the aggregation of blood formed elements at the gauze-wound interface to achieve efficient hemostasis.
[0023] The experimental results show that the hydrophobic modified gauze ball of the present invention is used for hemostasis after dental surgery, can resist saliva wetting, and promote the aggregation of blood components at the gauze-wound interface, thereby achieving efficient hemostasis.
[0024] Obviously, according to the above contents of the present invention, in accordance with common technical knowledge and customary means in the art, without departing from the above basic technical ideas of the present invention, other various forms of modification, replacement or change may be made.
[0025] The above contents of the present invention are further described in detail below through specific implementation methods in the form of examples. However, this should not be understood as the scope of the above subject matter of the present invention being limited to the following examples. All technologies realized based on the above contents of the present invention belong to the scope of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 Infrared characterization images of MS and MS-PDA@G.
[0027] Figure 2 The figure shows the contact angle test results of modified gauze with different surface particle densities.
[0028] Figure 3 Images of red blood cells adhered to the surface of modified gauze with different surface particle densities observed under scanning electron microscopy.
[0029] Figure 4 Comparison results of blood coagulation efficiency on modified gauze MS-PDA@G surfaces with different surface particle densities.
[0030] Figure 5 This is the comparison result of the in vitro coagulation time between modified gauze and ordinary gauze.
[0031] Figure 6 The results are a comparison of the in vivo hemostatic properties of modified gauze, ordinary gauze and Quikclot hemostatic gauze. DETAILED DESCRIPTION
[0032] The raw materials and equipment used in the present invention are all known products, which are obtained by purchasing commercially available products.
[0033] The "room temperature" referred to in the present invention is 25±5°C.
[0034] The conventional commercially available gauze used below is a Zhende medical non-woven fabric sheet, and the diameter of a single fiber is measured under an electron microscope to be approximately 15 μm.
[0035] Example 1. Preparation of hemostatic gauze ball
[0036] 1. Hydrophilic treatment of gauze substrate
[0037] A 10 mg / ml dopamine solution was prepared using Tris HCl buffer (pH ≈ 8.5) as solvent, and ultrasonic oxidation was performed for 30 seconds. A conventional commercially available gauze block was immersed in the solution and then dried at 60°C for 6 hours to obtain cellulose with a polydopamine layer (PDA@G). The gauze was washed with deionized water three times to remove the dopamine that was not polymerized and not bound to the cellulose, and dried at room temperature to obtain a hydrophilized gauze.
[0038] 2. Hydrophobicization of gauze surface
[0039] 10 mg of hydrophobized silica microspheres (MS) were ultrasonically dispersed in 2 mL of anhydrous ethanol and evenly sprayed on an area of about 50 cm using an electric spray gun. 2 The surface of the hydrophilized gauze was sprayed at a pressure of 1 MPa and a distance of 5-8 cm. The surface particle density of the modified gauze (MS-PDA@G) (i.e., the mass of the hydrophobized silica microspheres contained in the solution sprayed per unit area) was 0.5 mg / cm 2 . Dry at 60℃ for 4 hours, and then cut the modified gauze into 5×5cm 2 size.
[0040] 3. Assembly
[0041] Use the above 5×5cm 2 A 200 mg cotton ball is wrapped with modified gauze to form an oral hemostatic gauze ball.
[0042] The beneficial effects of the present invention are demonstrated by experimental examples below.
[0043] Experimental Example 1: Characterization and performance testing of modified gauze
[0044] 1. Experimental methods
[0045] (1) Characterization of MS and MS-PDA@G
[0046] The data were characterized by infrared spectra and Zeta potential results of MS and MS-PDA@G.
[0047] (2) Wetting gradient screening of MS-PDA@G
[0048] According to the method of Example 1, the gauze substrate was hydrophilized with a 10 mg / ml dopamine solution, and then a hydrophobically modified silica / ethanol suspension was prepared and the hydrophobic modified silica / ethanol suspension was prepared with 0.25, 0.5, 0.75, 1 mg / cm 2The surface particle density of the gauze was sprayed on the surface, and the contact angle experiment was tested; the modified yarns with different surface particle densities of 1cm×1cm were arranged in a 24-well plate, and then 50μl of red blood cell suspension was dropped on the surface of the gauze and incubated at 37℃ for 1 hour. The samples were washed 3 times with PBS, fixed with glutaraldehyde, dehydrated, and sprayed with gold, and the results were observed by scanning electron microscopy (SEM).
[0049] (3) Screening of coagulation efficiency of MS-PDA@G surfaces with different wettability
[0050] The blood coagulation index experiment was used to determine the coagulation efficiency of hydrophobic gauze with different surface particle densities. The specific operation is as follows:
[0051] Mix 50μl of rabbit whole blood treated with sodium citrate anticoagulation with 10μl of 0.25M calcium chloride, and immediately drip it onto the surface of 1cm×1cm modified gauze, and gently press it from above with the same modified gauze. At 1, 3, and 5 minutes, add 2ml of deionized water to lyse the red blood cells that have not formed clots. Take the supernatant and measure the hemoglobin absorbance at 541nm. In addition, 50μl of blood is dissolved in 2ml of deionized water to form a positive control, and its absorbance value is used as the denominator to calculate the blood coagulation index. The lower the index, the fewer red blood cells are not captured by the clot, that is, the higher the coagulation efficiency.
[0052] (4) In vitro coagulation effect of MS-PDA@G
[0053] 270 μl of anticoagulated rabbit blood and 30 μl of 0.25 M calcium chloride (CaCl2) solution were dripped into an EP tube filled with 1 cm×1 cm ordinary gauze (i.e., conventional commercially available gauze) or modified gauze. The EP tube was shaken every 10 seconds, and the time when the blood stopped flowing was observed and recorded.
[0054] (5) In vivo hemostatic performance of MS-PDA@G
[0055] 8 layers of 3×3cm 2 Ordinary gauze blocks and Quikclot US military hemostatic gauze of the same specifications were used as the control group, and a single layer of modified gauze was added to the wound side of the ordinary gauze block as the experimental group. A femoral artery injury model of male SD rats aged 4-6 weeks was used, with 5 rats in each group. After the rats were anesthetized and disinfected, the hair on one side of the groin was cut off, the skin and muscle fascia were separated, and the femoral artery was visible. The femoral artery was cut off, and after free bleeding for 10 seconds, a gauze block was used for compression with a pressure of about 50N. The bleeding of the wound was observed, and the bleeding area on the wound surface no longer expanded as the end point of hemostasis. The amount of bleeding and the time of hemostasis were calculated respectively, and the gauze image after hemostasis was recorded by taking photos.
[0056] 2. Experimental results
[0057] result( Figure 1 ) shows that at 2925cm -1 and 2854cm -1 There is a characteristic vibration peak of the hydrophobic alkyl chain at . Combined with the measurement result of Zeta potential of -54.82mV, it shows that the surface of hydrophobized silica microspheres carries a large amount of negative charge, which has the potential to interact with the positively charged erythrocyte membrane and promote erythrocyte aggregation.
[0058] Contact angle test results ( Figure 2 ) showed that each group had a certain degree of hydrophobicity, among which 0.5mg / cm 2 The group has the best wettability, which is manifested by the droplets being able to stay on the gauze surface and slowly pass through. In contrast, the low-density group gauze surface is not hydrophobic enough to effectively prevent the rapid infiltration of droplets, while the high-density group gauze shows too strong hydrophobicity, droplets cannot pass through, and does not have the effect of selectively agglutinating visible blood components. 2 The hydrophobic silica microspheres are sprayed at a density of 1000 nm to make the surface of the hydrophilic substrate hydrophobic, and the gauze prepared has the most ideal wetting gradient.
[0059] Through SEM observation ( Figure 3 ), found 0.5mg / cm 2 Under the surface particle density, blood slowly infiltrates the gauze surface, and a large number of red blood cells are intercepted; while the low surface particle density group is not hydrophobic enough, and most of the cells are lost into the gauze; the high surface particle density group is too hydrophobic and has no selective cell agglutination effect. 2 The surface particle density provides ideal asymmetric wettability with optimal procoagulant potential.
[0060] Experimental results ( Figure 4 ) shows that at 5 minutes, 0.5 mg / cm 2 The group showed the highest coagulation efficiency. 2 The gauze in the group had the lowest coagulation efficiency (0.25 and 0.5 mg / cm 2 P<0.01); while 0.75 and 1 mg / cm 2 The group has strong hydrophobicity and no blood concentration effect, and the coagulation efficiency is significantly lower than 0.5 mg / cm 2 Group.
[0061] Experimental results ( Figure 5 ) showed that compared with ordinary gauze, the modified gauze shortened the time required for blood clotting by about 90 seconds and significantly enhanced the coagulation effect.
[0062] result( Figure 6) showed that the hemostasis time of the experimental group was about 193 seconds, and the blood loss was about 338 mg, which were significantly lower than those of ordinary gauze and Quikclot gauze. This shows that simply adding a single layer of modified gauze on the surface of ordinary gauze can significantly enhance its hemostasis ability, and the effect is better than that of commercially available products.
[0063] From the above experimental results, it can be seen that by hydrophilizing the gauze substrate and hydrophobizing the gauze surface, a modified gauze with strong hydrophobicity and excellent coagulation effect can be obtained. In addition, by spraying hydrophobic silica microspheres at different densities to prepare gauze, it was found that 0.5 mg / cm 2 The spray density has the most ideal wetting gradient and the highest coagulation efficiency.
[0064] In summary, the present invention provides a hydrophobic modified gauze ball for dental hemostasis and a preparation method thereof. The hydrophobic modified gauze ball of the present invention is composed of an outer gauze and an inner cotton ball. The gauze is modified and then assembled with the cotton ball to prepare a hydrophobic modified gauze ball. Among them, the modification strategy includes hydrophilizing the outer gauze and modifying the outer gauze with hydrophobic compounds and spraying process. The hydrophobic modified gauze ball of the present invention is used for hemostasis after dental surgery, can resist saliva wetting, and promote the aggregation of blood formed elements at the gauze-wound interface to achieve efficient hemostasis.
Claims
1. A modified gauze, characterized in that: It is obtained by spraying a hydrophobic compound on gauze, wherein the density of the spraying is 0.1 to 1.5 mg / cm 2 .
2. The modified gauze according to claim 1, characterized in that: The gauze is a woven gauze or non-woven gauze with a mesh structure; The spraying process is electric spray gun spraying, dipping, spin coating, electrostatic spray spraying or chemical vapor deposition spraying; The hydrophobic compound is hydrophobic silica microspheres, long-chain alkyl silane, long-chain fatty acid, beeswax or paraffin; The density of the spraying is 0.25-1 mg / cm 2 .
3. The modified gauze according to claim 2, characterized in that: The spraying process is electric spray gun spraying; The hydrophobic compound is hydrophobic silica microspheres; The density of the spraying is 0.5 mg / cm 2 .
4. The modified gauze according to claim 1, characterized in that: The gauze is hydrophilized gauze.
5. The modified gauze according to claim 4, characterized in that: The hydrophilization treatment is hydrophilic compound modification, ultraviolet light modification, plasma modification, carboxymethylation modification or cellulase modification.
6. The modified gauze according to claim 5, characterized in that: The hydrophilic compound modification is a catechol compound modification.
7. The modified gauze according to claim 6, characterized in that: The hydrophilic compound modification is dopamine modification.
8. A hemostatic gauze ball, characterized in that: The invention is composed of the modified gauze described in any one of claims 1 to 7 and an absorbent cotton ball.
9. A method for preparing the hemostatic gauze ball according to claim 8, characterized in that: The method comprises the following steps: assembling the modified gauze and the absorbent cotton balls to obtain the product.
10. Use of the modified gauze according to any one of claims 1 to 7 and the hemostatic gauze ball according to claim 8 in the preparation of dental hemostatic materials.
